InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,481.26
(
0.06%
)
US TECH 100
19,248.40
(
0.17%
)
Dow Jones
39,194.77
(
0.17%
)
Brent Oil
84.88
(
0.48%
)
Bitcoin
61,736.42
(
1.52%
)
Post# of 492
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

7Card

Send PM Follow Ignore
Followers 5
Posts 861
Boards Moderated 0
Alias Born 02/23/2017

7Card

Re: imjake post# 99

Thursday, 10/24/2019 4:04:18 PM

Thursday, October 24, 2019 4:04:18 PM

Post# of 492
LexaGene owns the 2 original patents. Jack is the author.

Biotechs of this nature typically sell between $300M and $800M. Would like to see the upper end.

You are correct about the one time use cartridges being like the razor blade and high margin. They will make a ton on the sale of those. They have a lease to buy program for the LX2 that will make it easy for anyone to afford to own one. That will be a big assist for sales too.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up